Ameena Westwood, 53, from Smethwick, West Midlands, was diagnosed with breast cancer six years ago and had a mastectomy and ...

Successful test in breast cancer patients: the active agent digoxin, a cardiac medication, dissolves clusters of circulating breast cancer cells in the blood, thus reducing the risk of metastases ...

Virginia G. Kaklamani, MD, DSc, discusses datopotamab deruxtecan and other antibody-drug conjugates available for patients with unresectable or metastatic hormone receptor-positive, HER2-negative ...

Certain tumor types do not remain at their point of origin but spread throughout the body and form metastases. This is ...

LONDON - ANGLE plc, a leading liquid biopsy company, has announced a significant development in cancer treatment strategy, ...

Two U.S. companies teamed up to treat cancer patients using an unproven blood filter in Antigua, out of reach of American ...

Both Harvard University and Johns Hopkins University sites were recently added as participating sites in FLAMINGO-01 in the US and both principal investigators, Dr. Laura Spring and Dr. Cesar ...

The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed.

Findings showed datopotamab deruxtecan reduced the risk of disease progression or death by 37% compared with chemotherapy.

Legacy projects can help someone with metastatic breast cancer leave behind a lasting impact that will be remembered after ...

Individuals with advanced breast cancer at diagnosis are more likely to have prevalent cardiovascular disease.